Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Mar;3(2):151–155. doi: 10.1128/cdli.3.2.151-155.1996

Expression of the somatostatin gene in human astrocytoma cell lines.

L Mercure 1, G S Tannenbaum 1, H M Schipper 1, D Phaneuf 1, M A Wainberg 1
PMCID: PMC170265  PMID: 8991628

Abstract

Somatostatin (somatotropin release-inhibiting hormone; SRIH) has been demonstrated in neurons of the central nervous system (CNS) as well as in endocrine cells of the pancreas and gastrointestinal tract and can suppress various immune functions including lymphocyte proliferation, immunoglobulin synthesis, and cytokine production. Since astrocytes possess antigen-presenting activity and can secrete a wide array of immunoregulatory and inflammatory cytokines, we studied SRIH gene expression in both astrocyte cell lines and mitogen-stimulated peripheral blood mononuclear leukocytes from healthy donors. We now report by means of a complementary DNA-based reverse transcription PCR that differential levels of SRIH mRNA were expressed in 9 of 11 human astrocytoma cell lines tested but were undetectable in activated peripheral blood mononuclear leukocytes as well as in a variety of human lymphocyte and monocyte cell lines. The synthesis and secretion of SRIH protein by astrocytoma cells that expressed SRIH transcripts were confirmed by specific radioimmunoassay of cell culture fluids. These findings support the notion that SRIH gene expression occurs in human astrocytoma cells but not in mature lymphoid cells of the immune system.

Full Text

The Full Text of this article is available as a PDF (349.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguila M. C., Dees W. L., Haensly W. E., McCann S. M. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11485–11489. doi: 10.1073/pnas.88.24.11485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bhathena S. J., Louie J., Schechter G. P., Redman R. S., Wahl L., Recant L. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes. 1981 Feb;30(2):127–131. doi: 10.2337/diab.30.2.127. [DOI] [PubMed] [Google Scholar]
  3. Blum A. M., Metwali A., Mathew R. C., Cook G., Elliott D., Weinstock J. V. Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-gamma secretion. J Immunol. 1992 Dec 1;149(11):3621–3626. [PubMed] [Google Scholar]
  4. Brazeau P., Ling N., Böhlen P., Esch F., Ying S. Y., Guillemin R. Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7909–7913. doi: 10.1073/pnas.79.24.7909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eddleston M., Mucke L. Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience. 1993 May;54(1):15–36. doi: 10.1016/0306-4522(93)90380-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fontana A., Fierz W. The endothelium--astrocyte immune control system of the brain. Springer Semin Immunopathol. 1985;8(1-2):57–70. doi: 10.1007/BF00197247. [DOI] [PubMed] [Google Scholar]
  7. Fontana A., Hengartner H., de Tribolet N., Weber E. Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol. 1984 Apr;132(4):1837–1844. [PubMed] [Google Scholar]
  8. Fuller P. J., Verity K. Somatostatin gene expression in the thymus gland. J Immunol. 1989 Aug 1;143(3):1015–1017. [PubMed] [Google Scholar]
  9. Goetzl E. J., Payan D. G. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol. 1984 Dec;133(6):3255–3259. [PubMed] [Google Scholar]
  10. Goodman R. H., Montminy M. R., Low M. J., Habener J. F. Biosynthesis of rat preprosomatostatin. Adv Exp Med Biol. 1985;188:31–47. doi: 10.1007/978-1-4615-7886-4_3. [DOI] [PubMed] [Google Scholar]
  11. Gu Z., Gao Q., Faust E. A., Wainberg M. A. Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC. J Gen Virol. 1995 Oct;76(Pt 10):2601–2605. doi: 10.1099/0022-1317-76-10-2601. [DOI] [PubMed] [Google Scholar]
  12. Harbour-McMenamin D., Smith E. M., Blalock J. E. Production of immunoreactive chorionic gonadotropin during mixed lymphocyte reactions: a possible selective mechanism for genetic diversity. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6834–6838. doi: 10.1073/pnas.83.18.6834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Haynes D. R., Whitehouse M. W., Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology. 1992 Jun;76(2):251–257. [PMC free article] [PubMed] [Google Scholar]
  14. Hinterberger W., Cerny C., Kinast H., Pointner H., Tragl K. H. Somatostatin reduces the release of colony-stimulating activity (CSA) from PHA-activated mouse spleen lymphocytes. Experientia. 1978 Jul 15;34(7):860–862. doi: 10.1007/BF01939667. [DOI] [PubMed] [Google Scholar]
  15. Hiruma K., Koike T., Nakamura H., Sumida T., Maeda T., Tomioka H., Yoshida S., Fujita T. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology. 1990 Dec;71(4):480–485. [PMC free article] [PubMed] [Google Scholar]
  16. Kimata H., Yoshida A., Fujimoto M., Mikawa H. Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol. 1993 May 15;150(10):4630–4640. [PubMed] [Google Scholar]
  17. Lygren I., Revhaug A., Burhol P. G., Giercksky K. E., Jenssen T. G. Vasoactive intestinal polypeptide and somatostatin in leucocytes. Scand J Clin Lab Invest. 1984 Jun;44(4):347–351. doi: 10.3109/00365518409083818. [DOI] [PubMed] [Google Scholar]
  18. Malec P., Zeman K., Markiewicz K., Tchórzewski H., Nowak Z., Baj Z. Short-term somatostatin infusion affects T lymphocyte responsiveness in humans. Immunopharmacology. 1989 Jan-Feb;17(1):45–49. doi: 10.1016/0162-3109(89)90007-6. [DOI] [PubMed] [Google Scholar]
  19. Mercure L., Brenner B. J., Phaneuf D., Tsoukas C., Wainberg M. A. Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes. Antimicrob Agents Chemother. 1994 May;38(5):986–990. doi: 10.1128/aac.38.5.986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mercure L., Phaneuf D., Wainberg M. A. Detection of unintegrated human immunodeficiency virus type 1 DNA in persistently infected CD8+ cells. J Gen Virol. 1993 Oct;74(Pt 10):2077–2083. doi: 10.1099/0022-1317-74-10-2077. [DOI] [PubMed] [Google Scholar]
  21. Mercure L., Phaneuf D., Wainberg M. A. Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes. Clin Diagn Lab Immunol. 1995 Mar;2(2):192–198. doi: 10.1128/cdli.2.2.192-198.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Muscettola M., Grasso G. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology. 1990 Jun;180(4-5):419–430. doi: 10.1016/S0171-2985(11)80303-7. [DOI] [PubMed] [Google Scholar]
  23. Ndoye A., Troutaud D., Rougier F., Deschaux P. In vitro effects of substance P and somatostatin on lymphoproliferation in rainbow trout (Salmo gairdneri). Ann N Y Acad Sci. 1992 Apr 15;650:160–164. doi: 10.1111/j.1749-6632.1992.tb49114.x. [DOI] [PubMed] [Google Scholar]
  24. Niedermühlbichler M., Wiedermann C. J. Suppression of superoxide release from human monocytes by somatostatin-related peptides. Regul Pept. 1992 Sep 3;41(1):39–47. doi: 10.1016/0167-0115(92)90512-s. [DOI] [PubMed] [Google Scholar]
  25. Nio D. A., Moylan R. N., Roche J. K. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J Immunol. 1993 Jun 15;150(12):5281–5288. [PubMed] [Google Scholar]
  26. Pawlikowski M., Zelazowski P., Stepien H. Enhancement of human lymphocyte natural killer activity by somatostatin. Neuropeptides. 1989 Feb-Mar;13(2):75–77. doi: 10.1016/0143-4179(89)90001-2. [DOI] [PubMed] [Google Scholar]
  27. Penman E., Wass J. A., Besser G. M., Rees L. H. Somatostatin secretion by lung and thymic tumours. Clin Endocrinol (Oxf) 1980 Dec;13(6):613–620. doi: 10.1111/j.1365-2265.1980.tb03430.x. [DOI] [PubMed] [Google Scholar]
  28. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med. 1993 Oct 21;329(17):1246–1253. doi: 10.1056/NEJM199310213291708. [DOI] [PubMed] [Google Scholar]
  29. Roth K. A., Lorenz R. G., Unanue R. A., Weaver C. T. Nonopiate active proenkephalin-derived peptides are secreted by T helper cells. FASEB J. 1989 Oct;3(12):2401–2407. doi: 10.1096/fasebj.3.12.2529160. [DOI] [PubMed] [Google Scholar]
  30. Shamah S. M., Stiles C. D., Guha A. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol Cell Biol. 1993 Dec;13(12):7203–7212. doi: 10.1128/mcb.13.12.7203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith E. M., Blalock J. E. Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7530–7534. doi: 10.1073/pnas.78.12.7530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Smith E. M., Morrill A. C., Meyer W. J., 3rd, Blalock J. E. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. 1986 Jun 26-Jul 2Nature. 321(6073):881–882. doi: 10.1038/321881a0. [DOI] [PubMed] [Google Scholar]
  33. Sreedharan S. P., Kodama K. T., Peterson K. E., Goetzl E. J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem. 1989 Jan 15;264(2):949–952. [PubMed] [Google Scholar]
  34. Stanisz A. M., Scicchitano R., Payan D. G., Bienenstock J. In vitro studies of immunoregulation by substance P and somatostatin. Ann N Y Acad Sci. 1987;496:217–225. doi: 10.1111/j.1749-6632.1987.tb35769.x. [DOI] [PubMed] [Google Scholar]
  35. Steinman L. Connections between the immune system and the nervous system. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7912–7914. doi: 10.1073/pnas.90.17.7912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sundler F., Carraway R. E., Håkanson R., Alumets J., Dubois M. P. Immunoreactive neurotensin and somatostatin in the chicken thymus. A chemical and histochemical study. Cell Tissue Res. 1978 Dec 12;194(3):367–376. doi: 10.1007/BF00236158. [DOI] [PubMed] [Google Scholar]
  37. Tannenbaum G. S., Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology. 1984 Nov;115(5):1952–1957. doi: 10.1210/endo-115-5-1952. [DOI] [PubMed] [Google Scholar]
  38. Tannenbaum G. S., Rorstad O., Brazeau P. Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology. 1979 Jun;104(6):1733–1738. doi: 10.1210/endo-104-6-1733. [DOI] [PubMed] [Google Scholar]
  39. Uetsuki T., Naito A., Nagata S., Kaziro Y. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. J Biol Chem. 1989 Apr 5;264(10):5791–5798. [PubMed] [Google Scholar]
  40. Vallejo M., Miller C. P., Habener J. F. Somatostatin gene transcription regulated by a bipartite pancreatic islet D-cell-specific enhancer coupled synergetically to a cAMP response element. J Biol Chem. 1992 Jun 25;267(18):12868–12875. [PubMed] [Google Scholar]
  41. Wahl S. M., Allen J. B., McCartney-Francis N., Morganti-Kossmann M. C., Kossmann T., Ellingsworth L., Mai U. E., Mergenhagen S. E., Orenstein J. M. Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med. 1991 Apr 1;173(4):981–991. doi: 10.1084/jem.173.4.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Weigent D. A., Blalock J. E. Immunoreactive growth hormone-releasing hormone in rat leukocytes. J Neuroimmunol. 1990 Sep-Oct;29(1-3):1–13. doi: 10.1016/0165-5728(90)90142-a. [DOI] [PubMed] [Google Scholar]
  43. Yousefi S., Ghazinouri A., Vaziri N., Tilles J., Carandang G., Cesario T. The effect of somatostatin on the production of human interferons by mononuclear cells. Proc Soc Exp Biol Med. 1990 Jun;194(2):114–118. doi: 10.3181/00379727-194-43065. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES